← Back to Clinical Trials
Recruiting Phase 1, Phase 2 NCT07094659

NCT07094659 Aging and Task-specific Training to Reduce Falls

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07094659
Status Recruiting
Phase Phase 1, Phase 2
Sponsor University of Illinois at Chicago
Condition Fall Prevention
Study Type INTERVENTIONAL
Enrollment 315 participants
Start Date 2026-08-15
Primary Completion 2029-05-31

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age 90 Years
Study Type INTERVENTIONAL
Interventions
Task-Specific Balance TrainingTreadmill Perturbation TrainingConventional Balance Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.

This trial targets 315 participants in total. It began in 2026-08-15 with a primary completion date of 2029-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to examine the effects of a novel task-specific balance training for reducing environmental falls in community ambulatory older adults who are at-risk of falling. The main questions it aims to answer are: * Does task-specific balance training improve the ability to prevent falling when unexpected perturbations such as slips and trips occur, and/or improve balance control during self-initiated movements? * Does task-specific balance training reduce real-life falls for 18 months after training? Researchers will compare task-specific balance training with conventional balance training and treadmill perturbation-based training to examine how this novel intervention compares to established interventions for improving balance. Participants who participate in the study will be asked to do the following: * Complete a pre-training assessment of their balance control, and then be randomized to one of three training groups: 1) task-specific balance training, 2) treadmill perturbation-based training, and 3) conventional balance training * Complete their assigned training protocol for 8 weeks (2x per week for a total of 16 sessions) * Complete 2 post-training assessments of their balance control, the first being completed immediately after the training is completed, and the second being completed 18 months after the training is completed * Wear a physical activity monitor for 18 months after completing the intervention to monitor their real life falls.

Eligibility Criteria

Inclusion Criteria: * 60 to 90 years of age to include community dwelling older adults * Understand English to ensure ability to safely complete study protocols * Able to walk independently for 1 block and 10 meters without an assistive device to ensure ability to complete exercises and reactive balance assessments * 'At-risk' adults: Participants who report experience of at least 1 fall in the past 12 months or participants who are categorized as at high fall- risk using our fall risk prediction model which can predict the risk of both slip and trip related falls. Exclusion Criteria: * Major surgery less than 6 months ago to avoid complications due to training * Hospitalization less than 3 months ago to avoid complications due to training * Taking any sedative drugs to avoid interference with training * Acute or uncontrolled neurological or cardiopulmonary or musculoskeletal or cancer diagnosis to avoid complications due to training * Have intact visual and auditory ability with or without corrective aids to avoid confounding effects on balance * Severe osteoporosis measured by a score of less than negative two point five on heel bone density scan to avoid complications due to training * Loss of sensation on monofilament test to avoid confounding effects on outcome assessments * Cognitive impairment indicated by a score of less than 25 out of 30 on the mini mental state exam to ensure ability to follow instructions for safety * Shortness of breath or uncontrolled pain higher than a three out of ten or inability to achieve age specified minimal distance on the 6 minute walk test for endurance to avoid complications due to training

Contact & Investigator

Central Contact

Tanvi Bhatt, PT, PhD

✉ tbhatt6@uic.edu

📞 312-355-4443

Frequently Asked Questions

Who can join the NCT07094659 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, up to 90 Years, studying Fall Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

What phase is the NCT07094659 trial and what does that mean for participants?

Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.

Is NCT07094659 currently recruiting?

Yes, NCT07094659 is actively recruiting participants. Contact the research team at tbhatt6@uic.edu for enrollment information.

Where is the NCT07094659 trial being conducted?

This trial is being conducted at Chicago, United States.

Who is sponsoring the NCT07094659 clinical trial?

NCT07094659 is sponsored by University of Illinois at Chicago. The trial plans to enroll 315 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology